Related references
Note: Only part of the references are listed.AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome
Silveli Suzuki-Hatano et al.
HUMAN GENE THERAPY (2019)
The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier
Juliette Hordeaux et al.
MOLECULAR THERAPY (2019)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Intrathecal Adeno-Associated Viral Vector-Mediated Gene Delivery for Adrenomyeloneuropathy
Yi Gong et al.
HUMAN GENE THERAPY (2019)
Effects of Neutralizing Antibody Production on AAV-PHP.B-Mediated Transduction of the Mouse Central Nervous System
Yoichiro Shinohara et al.
MOLECULAR NEUROBIOLOGY (2019)
Long-Term Sustained Effect of Liver-Targeted Adeno-Associated Virus Gene Therapy for Mitochondrial Neurogastrointestinal Encephalomyopathy
Javier Torres-Torronteras et al.
HUMAN GENE THERAPY (2018)
The current landscape for the treatment of mitochondrial disorders
Jesse Slone et al.
JOURNAL OF GENETICS AND GENOMICS (2018)
Epigenetic regulation of brain region-specific microglia clearance activity
Pinar Ayata et al.
NATURE NEUROSCIENCE (2018)
Development of Intrathecal AAV9 Gene Therapy for Giant Axonal Neuropathy
Rachel M. Bailey et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
Pasqualina Colella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Gene therapy for neurological disorders: progress and prospects
Benjamin E. Deverman et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Gene therapy for neurological disorders: progress and prospects (vol 17, pg 641, 2018)
Benjamin E. Deverman et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Purkinje Cell Signaling Deficits in Animal Models of Ataxia
Eriola Hoxha et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2018)
Novel pathogenic SLC25A46 splice-site mutation causes an optic atrophy spectrum disorder
M. Nguyen et al.
CLINICAL GENETICS (2017)
AAV9-based gene therapy partially ameliorates the clinical phenotype of a mouse model of Leigh syndrome
I. Di Meo et al.
GENE THERAPY (2017)
Manufacturing Clinical Grade Recombinant Adeno-Associated Virus Using Invertebrate Cell Lines
Robert M. Kotin et al.
HUMAN GENE THERAPY (2017)
Loss of SLC25A46 causes neurodegeneration by affecting mitochondrial dynamics and energy production in mice
Zhuo Li et al.
HUMAN MOLECULAR GENETICS (2017)
Rapid degradation of mutant SLC25A46 by the ubiquitin-proteasome system results in MFN1/2-mediated hyperfusion of mitochondria
Janos Steffen et al.
MOLECULAR BIOLOGY OF THE CELL (2017)
AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy
Giuseppe Morabito et al.
MOLECULAR THERAPY (2017)
Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection
Sean L. Hammond et al.
PLOS ONE (2017)
Bovine and murine models highlight novel roles for SLC25A46 in mitochondrial dynamics and metabolism, with implications for human and animal health
Amandine Duchesne et al.
PLOS GENETICS (2017)
Novel insights into SLC25A46-related pathologies in a genetic mouse model
Maria Eirini Terzenidou et al.
PLOS GENETICS (2017)
Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's Disease
Yoshihide Sehara et al.
HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2017)
MitoCarta2.0: an updated inventory of mammalian mitochondrial proteins
Sarah E. Calvo et al.
NUCLEIC ACIDS RESEARCH (2016)
Loss of function of SLC25A46 causes lethal congenital pontocerebellar hypoplasia
Jijun Wan et al.
BRAIN (2016)
SLC25A46 is required for mitochondrial lipid homeostasis and cristae maintenance and is responsible for Leigh syndrome
Alexandre Janer et al.
EMBO MOLECULAR MEDICINE (2016)
SLC25A46 Mutations Underlie Progressive Myoclonic Ataxia With Optic Atrophy and Neuropathy
Gavin Charlesworth et al.
MOVEMENT DISORDERS (2016)
Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
Benjamin E. Deverman et al.
NATURE BIOTECHNOLOGY (2016)
Phenotypic and functional characterization of Bst+/- mouse retina
Hamidreza Riazifar et al.
DISEASE MODELS & MECHANISMS (2015)
Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder
Alexander J. Abrams et al.
NATURE GENETICS (2015)
Mutations of Human NARS2, Encoding the Mitochondrial Asparaginyl-tRNA Synthetase, Cause Nonsyndromic Deafness and Leigh Syndrome
Mariella Simon et al.
PLOS GENETICS (2015)
Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy
Balaji Balakrishnan et al.
CURRENT GENE THERAPY (2014)
Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
Linn Fagerberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Review of Clinical Trials for Mitochondrial Disorders: 1997-2012
Douglas S. Kerr
NEUROTHERAPEUTICS (2013)
Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model
Li Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A RANDOMIZED TRIAL OF COENZYME Q10 IN MITOCHONDRIAL DISORDERS
Elisa I. Glover et al.
MUSCLE & NERVE (2010)
Controlling brain tumor growth by intraventricular administration of an AAV vector encoding IFN-β
D. H. Meijer et al.
CANCER GENE THERAPY (2009)
Adeno-associated virus integration: virus versus vector
R. H. Smith
GENE THERAPY (2008)
Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes
Alessandro Fraldi et al.
HUMAN MOLECULAR GENETICS (2007)
Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders
M. Christine Rodriguez et al.
MUSCLE & NERVE (2007)
Share Paper
